The objective of this EU-funded research project is to apply multi-omics (MOMICS) stratification biomarkers directed at patients with arterial hypertension (HT), in order to develop and validate targeted personalized treatment strategies. The HT-Advance approach will address the major causes of treatment failure in HT.
Funded by the European Union
Company Details
- Founded
- -
- Address
- The Major Causes Of Treatment Failure In Ht.
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- https://ht-advance.eu/
- Keywords
- hypertension, omics, endocrinology.
Ht-Advance Questions
Ht-Advance's website is https://ht-advance.eu/
Ht-Advance's LinkedIn profile is https://www.linkedin.com/company/ht-advance
Ht-Advance's industry is
Public Health
Ht-Advance's top competitors are
Diagnostic And Interventional Imaging,
Patiëntenvereniging Blaas- Of Nierkanker,
Julius Clinical,
Paris Cardiovascular Research Center - Parcc.
Ht-Advance's categories are Public Health
Ht-Advance's founding year is 2023
